Enhancing Patient Management Strategies by Dr Danny Meyersfeld

ENHANCING PATIENT MANAGEMENT STRATEGIES BY INCORPORATING
PHARMACOGENETICS FOR PRECISION PRESCRIBING

By Dr. Danny Meyersfeld

The talk will describe how a Pharmacogenetics test can be used to tailor medication to the individual patient; ensuring an optimal response and reducing risk for side effects. The medical community has become polarised in the use of pharmaceuticals; with some using them excessively, whilst others rule out their use completely. This talk proposes a balanced; where pharmaceuticals can be used for the right patient, at the right dosage.

Biography:

Dr. Danny Meyersfeld completed his PhD in Molecular Biology in 2005 at University of Witwatersrand, South Africa. Following two years of post-doctoral research, and passionate about the concept of personalised medicine, Danny set up DNAlysis Biotechnology, a company dedicated to the widespread adoption of genomic insights into clinical practice.

Danny is passionate about availing doctors in sub-Saharan Africa of the same tools that are available elsewhere in the world and is determined to ensure the appropriate and responsible integration of genetic tests into clinical practice. To this end, the DNAlysis portfolio of genetic tests has been developed with a focus on scientific integrity and accuracy, and a significant portion of time is spent on the upskilling of medical practitioners to try and ease the transition of complex genetics into medical practices.

NO NEED TO BOOK FOR THIS ONE – WE WILL SHARE THE ZOOM INVITE ON THE DAY.